Alessandro P Delitala1, Maria Grazia Pilia2, Liana Ferreli2, Francesco Loi2, Nicolò Curreli2, Lenuta Balaci2, David Schlessinger2, Francesco Cucca3. 1. Department of Clinical and Experimental MedicineUniversity of Sassari, Viale San Pietro 8, 07100 Sassari, ItalyIstituto di Ricerca Genetica e Biomedica (IRGB)Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Cagliari, ItalyLaboratory of GeneticsNational Institute on Aging, Baltimore, MD 21224, USADepartment of Biochemical ScienceUniversity of Sassari, Sassari, Italy aledelitala@tiscali.it. 2. Department of Clinical and Experimental MedicineUniversity of Sassari, Viale San Pietro 8, 07100 Sassari, ItalyIstituto di Ricerca Genetica e Biomedica (IRGB)Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Cagliari, ItalyLaboratory of GeneticsNational Institute on Aging, Baltimore, MD 21224, USADepartment of Biochemical ScienceUniversity of Sassari, Sassari, Italy. 3. Department of Clinical and Experimental MedicineUniversity of Sassari, Viale San Pietro 8, 07100 Sassari, ItalyIstituto di Ricerca Genetica e Biomedica (IRGB)Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Cagliari, ItalyLaboratory of GeneticsNational Institute on Aging, Baltimore, MD 21224, USADepartment of Biochemical ScienceUniversity of Sassari, Sassari, ItalyDepartment of Clinical and Experimental MedicineUniversity of Sassari, Viale San Pietro 8, 07100 Sassari, ItalyIstituto di Ricerca Genetica e Biomedica (IRGB)Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Cagliari, ItalyLaboratory of GeneticsNational Institute on Aging, Baltimore, MD 21224, USADepartment of Biochemical ScienceUniversity of Sassari, Sassari, ItalyDepartment of Clinical and Experimental MedicineUniversity of Sassari, Viale San Pietro 8, 07100 Sassari, ItalyIstituto di Ricerca Genetica e Biomedica (IRGB)Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Cagliari, ItalyLaboratory of GeneticsNational Institute on Aging, Baltimore, MD 21224, USADepartment of Biochemical ScienceUniversity of Sassari, Sassari, Italy.
Abstract
OBJECTIVE: To assess thyroid function, the presence of thyroid antibodies, as well as the presence of goiter and/or nodules in subjects without a prior diagnosis of thyroid disorders, in a region with mild to moderate iodine deficiency. DESIGN AND METHODS: This cross-sectional study is based on data obtained from first and third visits of participants in the Sardinian survey. We performed two different analyses. In one, we assessed the prevalence of unknown thyroid dysfunctions among 6252 subjects who had a medical examination and blood collection for assays of thyrotropin, free thyroxine, and antibodies against thyroperoxidase (AbTPO) and against thyroglobulin (AbTG). In a second analysis, we evaluated the frequency of undiagnosed goiter and nodules among 3377 subjects who had a thyroid ultrasound scan. Subjects were excluded if they had a previous history of thyroid disorders or presence of goiter and/or nodules, or thyroid surgery, or if they were taking drugs that could impair thyroid function. RESULTS: We found a low prevalence of overt thyroid dysfunction (hyperthyroidism 0.4% and hypothyroidism 0.7%). The rates of subclinical hypothyroidism and hyperthyroidism were 4.7 and 2.4% respectively. Almost 16% of participants were positive for at least one antibody and 5.2% for both AbTG and AbTPO. Nodules were detected in 17.4% of subjects and the prevalence of goiter was 22.1%. CONCLUSIONS: Undiagnosed biochemical thyroid dysfunctions, unknown nodules, and goiter were common in subjects living in a mild to moderate iodine-deficient area. In this community, thyroid disorders often go undetected and screening could be reasonable in subjects at a higher risk.
OBJECTIVE: To assess thyroid function, the presence of thyroid antibodies, as well as the presence of goiter and/or nodules in subjects without a prior diagnosis of thyroid disorders, in a region with mild to moderate iodine deficiency. DESIGN AND METHODS: This cross-sectional study is based on data obtained from first and third visits of participants in the Sardinian survey. We performed two different analyses. In one, we assessed the prevalence of unknown thyroid dysfunctions among 6252 subjects who had a medical examination and blood collection for assays of thyrotropin, free thyroxine, and antibodies against thyroperoxidase (AbTPO) and against thyroglobulin (AbTG). In a second analysis, we evaluated the frequency of undiagnosed goiter and nodules among 3377 subjects who had a thyroid ultrasound scan. Subjects were excluded if they had a previous history of thyroid disorders or presence of goiter and/or nodules, or thyroid surgery, or if they were taking drugs that could impair thyroid function. RESULTS: We found a low prevalence of overt thyroid dysfunction (hyperthyroidism 0.4% and hypothyroidism 0.7%). The rates of subclinical hypothyroidism and hyperthyroidism were 4.7 and 2.4% respectively. Almost 16% of participants were positive for at least one antibody and 5.2% for both AbTG and AbTPO. Nodules were detected in 17.4% of subjects and the prevalence of goiter was 22.1%. CONCLUSIONS: Undiagnosed biochemical thyroid dysfunctions, unknown nodules, and goiter were common in subjects living in a mild to moderate iodine-deficient area. In this community, thyroid disorders often go undetected and screening could be reasonable in subjects at a higher risk.
Authors: G F Fenzi; C Giani; P Ceccarelli; L Bartalena; E Macchia; F Aghini-Lombardi; P Vitti; R Lari; C Ceccarelli; L Baschieri Journal: J Endocrinol Invest Date: 1986-04 Impact factor: 4.256
Authors: A Costa; V de Filippis; A Balsamo; N Ravarino; O Testori; B Torchio; P Valmaggia; G Zoppetti Journal: Clin Exp Immunol Date: 1984-04 Impact factor: 4.330
Authors: T Bjoro; J Holmen; O Krüger; K Midthjell; K Hunstad; T Schreiner; L Sandnes; H Brochmann Journal: Eur J Endocrinol Date: 2000-11 Impact factor: 6.664
Authors: S Mariotti; P Sansoni; G Barbesino; P Caturegli; D Monti; A Cossarizza; T Giacomelli; G Passeri; U Fagiolo; A Pinchera Journal: Lancet Date: 1992-06-20 Impact factor: 79.321
Authors: C T Sawin; A Geller; P A Wolf; A J Belanger; E Baker; P Bacharach; P W Wilson; E J Benjamin; R B D'Agostino Journal: N Engl J Med Date: 1994-11-10 Impact factor: 91.245
Authors: E Martino; A Loviselli; F Velluzzi; M L Murtas; M Carta; M Lampis; R Murru; A Mastinu; M L Arba; V Sica Journal: J Endocrinol Invest Date: 1994-09 Impact factor: 4.256
Authors: Alessandro P Delitala; Maristella Steri; Edoardo Fiorillo; Michele Marongiu; Edward G Lakatta; David Schlessinger; Francesco Cucca Journal: Cytokine Date: 2018-08-30 Impact factor: 3.861
Authors: R Rodia; P E Meloni; V Ruggiero; S Mariotti; C Mascia; C Balestrieri; G Serra; M Conti; M Loi; F Pes; S Onali; A Perra; R Littera; F Velluzzi; L Chessa; F Boi Journal: J Endocrinol Invest Date: 2022-09-01 Impact factor: 5.467
Authors: Carole E Aubert; Douglas C Bauer; Bruno R da Costa; Martin Feller; Carole Rieben; Eleanor M Simonsick; Kristine Yaffe; Nicolas Rodondi Journal: Clin Endocrinol (Oxf) Date: 2017-09-14 Impact factor: 3.478
Authors: Carole Rieben; Daniel Segna; Bruno R da Costa; Tinh-Hai Collet; Layal Chaker; Carole E Aubert; Christine Baumgartner; Osvaldo P Almeida; Eef Hogervorst; Stella Trompet; Kamal Masaki; Simon P Mooijaart; Jacobijn Gussekloo; Robin P Peeters; Douglas C Bauer; Drahomir Aujesky; Nicolas Rodondi Journal: J Clin Endocrinol Metab Date: 2016-09-30 Impact factor: 5.958